Product image of Mirtazapin Sandoz (Mirtazapine) supplied by GNH India

Mirtazapin Sandoz

Active Ingredient:
Mirtazapine
Origin:
EU

Mirtazapin Sandoz (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapin Sandoz, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for oral use. It is indicated for the treatment of major depressive disorder in adult patients.

GNH India supplies Mirtazapin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mirtazapin Sandoz, a NaSSA antidepressant, is used within the mood‑disorder therapeutic area.

  • Major depressive disorder: alleviates depressive symptoms and improves functional outcomes in adults.
  • Depressive episodes with prominent anxiety: helps reduce anxiety‑related symptoms while treating depression.
  • Depression associated with insomnia: improves sleep quality and mood concurrently.

How It Works

  • Mirtazapine acts as an antagonist at central presynaptic α2‑adrenergic receptors, which increases norepinephrine release, and blocks 5‑HT2 and 5‑HT3 serotonin receptors, enhancing serotonergic transmission. It also antagonises H1 histamine receptors, contributing to its sedative properties. The combined effect results in elevated norepinephrine and serotonin activity in key brain pathways involved in mood regulation.

Side Effects

Mirtazapin Sandoz may cause a range of adverse reactions.

Common Side Effects

  • Sedation or drowsiness
  • Increased appetite and weight gain
  • Dry mouth
  • Constipation
  • Dizziness or light‑headedness
  • Orthostatic hypotension

Serious or Rare Side Effects

  • Agranulocytosis or severe neutropenia
  • Seizures
  • Suicidal thoughts or worsening depression
  • Hepatotoxicity (liver injury)
  • Serotonin syndrome, especially with other serotonergic drugs
  • Severe allergic reactions (e.g., angioedema)

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety measures.

  • Hepatic function: assess liver enzymes in patients with existing liver disease.
  • Suicidality: monitor for emergence or worsening of suicidal thoughts, especially early in treatment.
  • Cardiovascular status: use caution in patients with hypotension or arrhythmias.
  • Discontinuation: avoid abrupt cessation to reduce risk of withdrawal symptoms.
  • Drug interactions: review concomitant medications for potential additive CNS depression.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Mirtazapin Sandoz can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis or serotonin syndrome.
  • Other serotonergic agents (SSRIs, SNRIs, tramadol): increased risk of serotonin syndrome.
  • Strong CYP3A4 inhibitors (ketoconazole, itraconazole): may raise mirtazapine plasma levels.
  • CNS depressants (benzodiazepines, alcohol): additive sedation and respiratory depression.
  • H1‑antagonists with sedative properties: excessive drowsiness.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers (rifampin, carbamazepine): may reduce therapeutic effect.
  • Antihypertensive drugs: potential additive hypotensive effect.
  • Anticholinergic medications: may worsen dry mouth and constipation.
  • NSAIDs or anticoagulants: heightened risk of gastrointestinal bleeding.
  • Lithium: possible increase in neurotoxicity.

Frequently Asked Questions

Mirtazapin Sandoz contains the active ingredient mirtazapine and is prescribed for the treatment of major depressive disorder in adult patients. It helps alleviate depressive symptoms such as low mood, loss of interest, and associated anxiety, improving overall functional capacity.

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonising 5‑HT2 and 5‑HT3 serotonin receptors. This dual action enhances serotonergic and noradrenergic neurotransmission, contributing to mood elevation and anxiolysis.

The appropriate dose of Mirtazapin Sandoz is determined individually by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. Dosage adjustments are made according to professional guidelines and patient needs.

Safety data for mirtazapine in pregnancy and lactation are limited, and the product’s pregnancy category is unknown. Clinicians should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapin Sandoz (mirtazapine) belongs to the NaSSA class, differing from SSRIs and SNRIs by its combined noradrenergic and specific serotonergic activity and strong antihistamine effect. This profile often results in greater sedation and appetite stimulation, which can be advantageous for patients with insomnia or weight loss.

Mirtazapin Sandoz should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

The medication is taken orally, usually once daily in the evening, with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include agranulocytosis, severe neutropenia, seizures, hepatotoxicity, and the potential for suicidal thoughts or worsening depression, particularly during the initial treatment phase. Immediate medical attention is required if any of these events occur.

Mirtazapin Sandoz is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients, and in those currently receiving monoamine oxidase inhibitors (MAOIs). Caution is advised for individuals with severe hepatic impairment, uncontrolled cardiovascular disease, or a history of seizures.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mirtazapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT